Working… Menu
Trial record 1 of 4 for:    Nichi-Iko
Previous Study | Return to List | Next Study

A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02990806
Recruitment Status : Completed
First Posted : December 13, 2016
Last Update Posted : May 18, 2020
Information provided by (Responsible Party):
Nichi-Iko Pharmaceutical Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2019
Actual Study Completion Date : May 2019
Certification/Extension First Submitted : May 8, 2020